2D Layered Double Hydroxide Nanoparticles: Recent Progress toward Preclinical/Clinical Nanomedicine
Двумерные наночастицы слоистых двойных гидроксидов: последние достижения на пути к доклинической и клинической наномедицине
2019-08-20
SCID: 54.1/eh7yya89
Discuss with AI
2D nanomaterialsLDH nanomedicinegene-based and protein-based vaccineslayered double hydroxide nanoparticlessurface engineering
Figures from the paper
Abstract (AI)
Abstract 2D nanomaterials represent one of the next‐generation biomaterials with versatile physicochemical advantages that allow for diverse biomedical applications in disease diagnosis, prevention, and treatment. In particular, layered double hydroxide (LDH) nanoparticles, as a typical 2D nanomaterial, have recently shown unprecedented advances in controllable and simplified chemical construction, versatile surface engineering, and comprehensive biological investigation. To realize in vivo biomedical applications, recent efforts have been substantially devoted to a few critical aspects of LDH nanomedicine including nanoparticle stability in physiological environments, accumulation at the disease‐targeted site, selective biological response to the nanoparticle, systematic biosafety examination, integration with multiple diagnostic and therapeutic modalities, and the adjuvant activity and suitability for gene‐based and protein‐based vaccines, which are herein comprehensively reviewed. The challenges and future development strategies of LDH nanomedicine are also discussed toward practical biomedical applications to benefit patients.
Key Findings
1
LDH nanomedicine is increasingly integrated with multiple diagnostic and therapeutic modalities and investigated as an adjuvant for gene- and protein-based vaccines.
2
Layered double hydroxide nanoparticles are highlighted as versatile two-dimensional biomaterials for disease diagnosis, prevention, and treatment.
3
Progress toward in vivo applications focuses on physiological stability, disease-site accumulation, selective biological responses, and systematic biosafety evaluation.
4
Recent advances have enabled more controllable and simplified LDH chemical construction, versatile surface engineering, and broader biological investigation.
5
Translation to practical biomedical applications remains challenged by nanoparticle stability, targeting, biological selectivity, safety, and the need for optimized development strategies.
Research Object
layered double hydroxide (LDH) nanoparticles for biomedical applications
Research Subject
their physicochemical construction and surface engineering, physiological stability, disease-site accumulation, selective biological responses, biosafety, multimodal diagnostic and therapeutic integration, and adjuvant suitability for gene- and protein-based vaccines
Publication Details
Publication Date
2019-08-20
Journal
Publisher
ISSN
Cited by
150
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest